Age-dependent differential crosstalk between alpha(1)-adrenergic and angiotensin receptors

Canadian Journal of Cardiology

Volumn 25, Issue 8, 2009, Pages 481-485

  Li, Yan Fang ^a   Shi, Shu Tian ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Age factors; Alpha(1) adrenergic receptor; Angiotensin type 1 receptor; Angiotensin type 2 receptor; Crosstalk

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; CYCLIC GMP; CYTOSOLIC PHOSPHOLIPASE A2; LOSARTAN; PHENYLEPHRINE; PROTEIN TYROSINE KINASE;

AGE; AGED; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR RISK; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART LEFT ATRIUM; HEART MUSCLE CONTRACTILITY; INOTROPISM; MALE; MOLECULAR INTERACTION; NONHUMAN; PROTEIN CONTENT; PROTEIN PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION;

EID: 68949135181     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(09)70123-0     Document Type: Article

References (47)

1. Paravicini TM, Touyz RM. Redox signaling in hypertension. Cardiovasc Res 2006;71:247-58.
2. Crowley SD, Gurley SB, Herrera MJ, et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A 2006;103:17985-90.
3. Heymes C, Swynghedauw B, Chevalier B. Activation of angiotensinogen and angiotensin-converting enzyme gene expression in the left ventricle of senescent rats. Circulation 1994;90:1328-33.
4. de Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000;52:415-72.
5. 2 receptors: Cardiovascular hope or hype. Br J Pharmacol 2003;140:809-24.
6. Shi ST, Li YF. Interaction of signal transduction between angiotensin ATI and AT2 receptor subtypes in rat senescent heart. Chin Med J (Engl) 2007;120:1820-4.
7. Victor RG. Pathophysiology of target-organ disease: Does angiotensin II remain the key? J Clin Hypertens (Greenwich) 2007;9(11 Suppl 4):4-10.
8. Böhm M. Angiotensin receptor blockers versus angiotensin-converting enzyme inhibitors: Where do we stand now? Am J Cardiol 2007;100:38J-44J.
9. Hudson M, Humphries K, Tu JV, Behlouli H, Sheppard R, Pilote L. Angiotensin II receptor blockers for the treatment of heart failure: A class effect? Pharmacotherapy 2007;27:526-34.
10. Milligan G. Constitutive activity and inverse agonists of G protein-coupled receptors: A current perspective. Mol Pharmacol 2003;64:1271-6.
11. Li HT, Long CS, Gray MO, Rokosh DG, Honbo NY, Karliner JS. Cross talk between angiotensin AT1 and alpha 1-adrenergic receptors: Angiotensin II downregulates alpha 1a-adrenergic receptor subtype mRNA and density in neonatal rat cardiac myocytes. Circ Res 1997;81:396-403.
12. Saxena PR. Interaction between the renin-angiotensin aldosterone and sympathetic nervous system. J Cardiovasc Pharmacol 1992;19:S80-8.
13. Goldsmith SR. Interactions between the sympathetic nervous system and the RAAS in heart failure. Curr Heart Fail Rep 2004;1:45-50.
14. Campese VM, Shaohua Y, Huiquin Z. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 2005;46:533-9.
15. Dubinion JH, Mi Z, Jackson EK. Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats. J Pharmacol Exp Ther 2006;317:1330-6.
16. Henegar JR, Brower GL, Kabour A, Janicki JS. Catecholamine response to chronic ANG II infusion and its role in myocyte and coronary vascular damage. Am J Physiol 1995;269:H1564-9.
17. Crespo MJ. Interaction between AT1 and alpha-1-adrenergic receptors in cardiomyopathic hamsters. J Card Fail 2000;6:257-63.
18. Yang H, Lu D, Raizada MK. Lack of cross talk between alpha-1-adrenergic and angiotensin type 1 receptors in neurons of spontaneously hypertensive rat brain. Hypertension 1996;27:1277-83.
19. Du Y, Qiu J, Nelson SH, et al. Regulation of type 1 Ang II receptor in vascular tissue: Role of [alpha]1-adrenoreceptor. Am J Physiol 1997;273:R1224-9.
20. Jerez S, Feral de Bruno M, Coviello A. Cross talk between angiotensin II and alpha 1 adrenergic receptors in rabbit aorta: Role of endothelium. J Cardiovasc Pharmacol 2004;43:402-9.
21. Barki-Harrington L, Luttrell LM, Rockman HA. Dual inhibition of beta-adrenergic and angiotensin II receptors by a single antagonist: A functional role for receptor-receptor interaction in vivo. Circulation 2003;108:1611-8.
22. National Institutes of Health. Guide for the Care and Use of Laboratory Animals. Washington: The National Academies Press, 1996.
23. Yu GS, Han C. Role of alpha 1A- and alpha 1B-adrenoceptors in phenylephrine-induced positive inotropic response in isolated rat left atrium. J Cardiovasc Pharmacol 1994;24:745-52.
24. Gether U. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 2000;21:90-113.
25. Möllmann H, Schmidt-Schweda S, Nef H, et al. Contractile effects of angiotensin and endothelin in failing and non-failing human hearts. Int J Cardiol 2007;114:34-40.
26. Allen IS, Cohen NM, Dhallan RS, Gaa ST, Lederer WJ, Rogers TB. Angiotensin II increases spontaneous contractile frequency and stimulates calcium current in cultured neonatal rat heart myocytes: Insights into the underlying biochemical mechanisms. Circ Res 1988;62:524-34.
27. Baker KM, Singer HA. Identification and characterization of guinea pig angiotensin II ventricular and atrial receptors: Coupling to inositol phosphate production. Circ Res 1988;62:896-904.
28. Hu ZW, Shi XY, Okazaki M, Hoffman BB. Angiotensin II induces transcription and expression of 1-adrenergic receptors in vascular smooth muscle cells. Am J Physiol 1995;268:H1006-14.
29. Zhang YZ, Zhang YY, Chen MZ, Han QD. beta-Adrenoceptors potentiate alpha1-adrenoceptor-mediated inotropic response in rat left atria. Acta Pharmacol Sin 2004;25:29-34.
30. Grimm M, Mahnecke N, Soja F, et al. The MLCK-mediated alpha-1-adrenergic inotropic effect in atrial myocardium is negatively modulated by PKC epsilon signaling. Br J Pharmacol 2006;148:991-1000.
31. 2+ in the heart: Contraction versus intracellular signaling. J Clin Invest 2006; 116:623-6.
32. Libonati JR, Eberli FR, Sesselberg HW, Apstein CS. Effects of low-flow ischemia on the positive inotropic action of angiotensin II in isolated rabbit and rat hearts. Cardiovasc Res 1997;33:71-81.
33. Balla T, Varnai P, Tian Y, Smith RD. Signaling events activated by angiotensin II receptors: What goes before and after the calcium signals. Endocr Res 1998;24:335-44.
34. Heymes C, Silvestre JS, Llorens-Cortes C, et al. Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes. Endocrinology 1998;139:2579-87.
35. Shivakumar K, Dostal DE, Boheler K, Baker KM, Lakatta EG. Differential response of cardiac fibroblasts from young adult and senescent rats to ANG II. Am J Physiol Heart Circ Physiol 2003;284:H1454-9.
36. Marano G, Argiolas L. Postjunctional regulation by angiotensin II of alpha 1-adrenoceptor-mediated pressor responses in the rat. Eur J Pharmacol 1994;261:121-6.
37. Mehta PK, Griendling KK. Angiotensin II cell signaling: Physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 2007;292:C82-97.
38. Hunyady L, Catt KJ. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol 2006;20:953-70.
39. Yin G, Yan C, Berk BC. Angiotensin II signaling pathways mediated by tyrosine kinases. Int J Biochem Cell Biol 2003;35:780-3.
40. Olivares-Reyes JA, Shah BH, Hernandez-Aranda J, et al. Agonist induced interactions between angiotensin AT1 and epidermal growth factor receptors. Mol Pharmacol 2005;68:356-64.
41. Korzick DH, Holiman DA, Boluyt MO, Laughlin MH, Lakatta EG. Diminished alpha-1-adrenergic-mediated contraction and translocation of PKC in senescent rat heart. Am J Physiol Heart Circ Physiol 2001;281:H581-9.
42. Nouet S, Nahmias C. Signal transduction from the angiotensin II AT2 receptor. Trends Endocrinol Metab 2000;11:1-6.
43. Steckelings UM, Kaschina E, Unger T. The AT2 receptor - a matter of love and hate. Peptides 2005;26:1401-9.
44. Lopez JJ, Lorell BH, Ingelfinger JR, et al. Distribution and function of cardiac angiotensin AT1, and AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol 1994;267:H844-52.
45. Jones ES, Black MJ, Widdop RE. Angiotensin AT2 receptor contributes to cardiovascular remodelling of aged rats during chronic AT1 receptor blockade. J Mol Cell Cardiol 2004;37:1023-30.
46. Widdop RE, Jones ES, Hannan RE, Gaspari TA. Angiotensin AT2 receptors: Cardiovascular hope or hype. Br J Pharmacol 2003;140:809-24.
47. Schunkert H, Weinberg EO, Bruckschlegel G, Rigger AJ, Lorell BH. Alteration of growth responses in established cardiac pressure overload hypertrophy in rats with aortic banding. J Clin Invest 1995;96:2768-74.